{
  "schema_version": "2.0",
  "doc_id": "2d78076333191bda346b23c6db3ec086d875bc4de37bca55597c3d5dbbfe9940",
  "extracted_at": "2026-02-01T08:46:30.751268+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "Compound",
      "name": "PDE4 cyclic nucleotide phosphodiesterases",
      "attributes": {
        "context": "The PDE4 cyclic nucleotide phosphodiesterases are essential regulators"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_002",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "regulators of cAMP abundance"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_003",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "regulate PKA activity"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_004",
      "type": "Compound",
      "name": "CREB",
      "attributes": {
        "context": "phosphorylation of CREB"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_005",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "PDE4 inhibitors have been shown"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_006",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "have antidepressant and memory-enhancing activity"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_007",
      "type": "PharmEffect",
      "name": "memory-enhancing activity",
      "attributes": {
        "context": "antidepressant and memory-enhancing activity"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_008",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "clinically-useful PDE4 inhibitors for CNS disorders"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_009",
      "type": "Indication",
      "name": "CNS disorders",
      "attributes": {
        "context": "PDE4 inhibitors for CNS disorders"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_010",
      "type": "Compound",
      "name": "PDE4 enzymes",
      "attributes": {
        "context": "configuration of PDE4 enzymes"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_011",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "the \u201clong\u201d PDE4 isoforms"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_012",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "development of a new generation of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_013",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "act on long PDE4 isoforms"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_014",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "These next generation PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_015",
      "type": "Compound",
      "name": "RACK1",
      "attributes": {
        "context": "such as RACK1, \\beta-arrestin, and DISC1"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_016",
      "type": "Compound",
      "name": "\\beta-arrestin",
      "attributes": {
        "context": "RACK1, \\beta-arrestin, and DISC1"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_017",
      "type": "Compound",
      "name": "DISC1",
      "attributes": {
        "context": "\\beta-arrestin, and DISC1"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_018",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "affect cAMP levels"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_019",
      "type": "PharmEffect",
      "name": "synaptic plasticity",
      "attributes": {
        "context": "such as synaptic plasticity"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_020",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "target PDE4 populations"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_021",
      "type": "PharmEffect",
      "name": "learning and memory",
      "attributes": {
        "context": "implicated in learning and memory, affect, and cognition"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_022",
      "type": "PharmEffect",
      "name": "affect",
      "attributes": {
        "context": "learning and memory, affect, and cognition"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_023",
      "type": "PharmEffect",
      "name": "cognition",
      "attributes": {
        "context": "affect, and cognition"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_024",
      "type": "Indication",
      "name": "affective disorders",
      "attributes": {
        "context": "include affective disorders, memory enhancement, and neurogenesis"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_025",
      "type": "PharmEffect",
      "name": "memory enhancement",
      "attributes": {
        "context": "affective disorders, memory enhancement, and neurogenesis"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_026",
      "type": "PharmEffect",
      "name": "neurogenesis",
      "attributes": {
        "context": "memory enhancement, and neurogenesis"
      },
      "source_chunk_ids": [
        "d09ff73e20df2dbdce19504cd9c6b5cb"
      ]
    },
    {
      "id": "ent_027",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "Keywords cAMP"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_028",
      "type": "Compound",
      "name": "Phosphodiesterase",
      "attributes": {
        "context": "Phosphodiesterase"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_029",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "PDE4"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_030",
      "type": "Compound",
      "name": "Beta-arrestin",
      "attributes": {
        "context": "Beta-arrestin"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_031",
      "type": "Compound",
      "name": "RACK1",
      "attributes": {
        "context": "RACK1"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_032",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "PKA"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_033",
      "type": "Compound",
      "name": "ERK1/2",
      "attributes": {
        "context": "ERK1/2"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_034",
      "type": "PharmEffect",
      "name": "Learning",
      "attributes": {
        "context": "Learning"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_035",
      "type": "PharmEffect",
      "name": "Memory",
      "attributes": {
        "context": "Memory"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_036",
      "type": "Indication",
      "name": "Depression",
      "attributes": {
        "context": "Depression"
      },
      "source_chunk_ids": [
        "2f41660756df8077b225e34df14ab812"
      ]
    },
    {
      "id": "ent_037",
      "type": "Compound",
      "name": "PDE4-selective inhibitors",
      "attributes": {
        "context": "As all PDE4-selective inhibitors act"
      },
      "source_chunk_ids": [
        "94207ef8c9b8fc504579199265447f14"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "PDE4 enzymes",
      "attributes": {
        "context": "catalytic sites of the PDE4 enzymes"
      },
      "source_chunk_ids": [
        "94207ef8c9b8fc504579199265447f14"
      ]
    },
    {
      "id": "ent_039",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "inhibitors of cAMP hydrolysis"
      },
      "source_chunk_ids": [
        "94207ef8c9b8fc504579199265447f14"
      ]
    },
    {
      "id": "ent_040",
      "type": "Compound",
      "name": "inhibitors",
      "attributes": {
        "context": "development of inhibitors selective"
      },
      "source_chunk_ids": [
        "94207ef8c9b8fc504579199265447f14"
      ]
    },
    {
      "id": "ent_041",
      "type": "Compound",
      "name": "compounds",
      "attributes": {
        "context": "some newer compounds may be more selective"
      },
      "source_chunk_ids": [
        "94207ef8c9b8fc504579199265447f14"
      ]
    },
    {
      "id": "ent_042",
      "type": "Compound",
      "name": "PDE4-selective inhibitors",
      "attributes": {
        "context": "most PDE4-selective inhibitors have less than a tenfold difference"
      },
      "source_chunk_ids": [
        "94207ef8c9b8fc504579199265447f14"
      ]
    },
    {
      "id": "ent_043",
      "type": "Concentration",
      "name": "IC_{50}",
      "attributes": {
        "context": "potency (i.e., IC_{50})"
      },
      "source_chunk_ids": [
        "94207ef8c9b8fc504579199265447f14"
      ]
    },
    {
      "id": "ent_044",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "Long PDE4 isoforms, such as PDE4B1 and PDE4D5"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_045",
      "type": "Compound",
      "name": "PDE4D5",
      "attributes": {
        "context": "Long PDE4 isoforms, such as PDE4B1 and PDE4D5"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_046",
      "type": "Compound",
      "name": "UCR1",
      "attributes": {
        "context": "interaction between specific regions of UCR1 and UCR2"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_047",
      "type": "Compound",
      "name": "UCR2",
      "attributes": {
        "context": "interaction between specific regions of UCR1 and UCR2"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_048",
      "type": "Compound",
      "name": "catalytic domain",
      "attributes": {
        "context": "interacted with the catalytic domain"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_049",
      "type": "Compound",
      "name": "Asp463",
      "attributes": {
        "context": "electrostatic interactions between Asp463 and Arg499"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_050",
      "type": "Compound",
      "name": "Arg499",
      "attributes": {
        "context": "electrostatic interactions between Asp463 and Arg499"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_051",
      "type": "Compound",
      "name": "Asp 471",
      "attributes": {
        "context": "Asp 471 and Arg507 in PDE4B1"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_052",
      "type": "Compound",
      "name": "Arg507",
      "attributes": {
        "context": "Asp 471 and Arg507 in PDE4B1"
      },
      "source_chunk_ids": [
        "17585205a23ec9e8a39b10d734b85442"
      ]
    },
    {
      "id": "ent_053",
      "type": "PharmEffect",
      "name": "improved tolerability",
      "attributes": {
        "context": "account for their improved tolerability in inflammatory and pulmonary disorders"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_054",
      "type": "Indication",
      "name": "inflammatory disorders",
      "attributes": {
        "context": "tolerability in inflammatory and pulmonary disorders"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_055",
      "type": "Indication",
      "name": "pulmonary disorders",
      "attributes": {
        "context": "tolerability in inflammatory and pulmonary disorders"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_056",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "older agents, such as rolipram"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_057",
      "type": "PharmEffect",
      "name": "potency",
      "attributes": {
        "context": "reduces their potency in the CNS"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_058",
      "type": "PharmEffect",
      "name": "CNS-selectivity",
      "attributes": {
        "context": "optimize the CNS-selectivity and effectiveness of PDE4-selective inhibitors"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_059",
      "type": "PharmEffect",
      "name": "effectiveness",
      "attributes": {
        "context": "optimize the CNS-selectivity and effectiveness of PDE4-selective inhibitors"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_060",
      "type": "Compound",
      "name": "PDE4-selective inhibitors",
      "attributes": {
        "context": "effectiveness of PDE4-selective inhibitors"
      },
      "source_chunk_ids": [
        "f24cd77f434befb7485fec851ccfbe9a"
      ]
    },
    {
      "id": "ent_061",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "The functions of PDE4 isoforms are dynamically regulated"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_062",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "phosphorylation by kinases such as PKA"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_063",
      "type": "Compound",
      "name": "ERK1/2",
      "attributes": {
        "context": "kinases such as PKA, ERK1/2"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_064",
      "type": "Compound",
      "name": "MK2",
      "attributes": {
        "context": "kinases such as PKA, ERK1/2, MK2"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_065",
      "type": "Compound",
      "name": "AMPK",
      "attributes": {
        "context": "kinases such as PKA, ERK1/2, MK2, and AMPK"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_066",
      "type": "Compound",
      "name": "ubiquitination",
      "attributes": {
        "context": "modification by ubiquitination"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_067",
      "type": "Compound",
      "name": "sumoylation",
      "attributes": {
        "context": "modification by ubiquitination and sumoylation"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_068",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "The activity of all long PDE4 isoforms is increased"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_069",
      "type": "PharmEffect",
      "name": "increased",
      "attributes": {
        "context": "activity of all long PDE4 isoforms is increased"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_070",
      "type": "Concentration",
      "name": "two- to sixfold",
      "attributes": {
        "context": "increased by two- to sixfold"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_071",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "upon PKA phosphorylation"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_072",
      "type": "PharmEffect",
      "name": "inhibited",
      "attributes": {
        "context": "ability of the enzyme to be inhibited"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "inhibitors, such as rolipram"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_074",
      "type": "Compound",
      "name": "ERK1/2",
      "attributes": {
        "context": "ERK1/2 phosphorylation attenuates PDE activity"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_075",
      "type": "PharmEffect",
      "name": "attenuates PDE activity",
      "attributes": {
        "context": "ERK1/2 phosphorylation attenuates PDE activity"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_076",
      "type": "Compound",
      "name": "MK2 kinase",
      "attributes": {
        "context": "MK2 kinase serves to attenuate"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_077",
      "type": "PharmEffect",
      "name": "attenuate the degree of activation",
      "attributes": {
        "context": "attenuate the degree of activation conferred by PKA phosphorylation"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_078",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "activation conferred by PKA phosphorylation"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_079",
      "type": "Compound",
      "name": "PDE4D5",
      "attributes": {
        "context": "in the case of PDE4D5"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_080",
      "type": "Compound",
      "name": "mono-ubiquitination",
      "attributes": {
        "context": "site for mono-ubiquitination"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_081",
      "type": "Compound",
      "name": "\\beta-arrestin",
      "attributes": {
        "context": "by the \\beta-arrestin-sequestered E3 ligase"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_082",
      "type": "Compound",
      "name": "E3 ligase",
      "attributes": {
        "context": "\\beta-arrestin-sequestered E3 ligase"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_083",
      "type": "Compound",
      "name": "Mdm3",
      "attributes": {
        "context": "E3 ligase, Mdm3"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_084",
      "type": "Compound",
      "name": "poly-ubiquitination",
      "attributes": {
        "context": "gates poly-ubiquitination"
      },
      "source_chunk_ids": [
        "1bd60cbc6345bfdc66520f9424dfd68f"
      ]
    },
    {
      "id": "ent_085",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "effects of phosphorylation on PDE4 dimerization"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_086",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "PKA phosphorylates a site"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_087",
      "type": "Compound",
      "name": "PDE4D3",
      "attributes": {
        "context": "S54 in PDE4D3"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_088",
      "type": "Compound",
      "name": "PDE4D5",
      "attributes": {
        "context": "S126 in PDE4D5"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_089",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "S133 in PDE4B1"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_090",
      "type": "Compound",
      "name": "QRRES",
      "attributes": {
        "context": "in the motif QRRES"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_091",
      "type": "Compound",
      "name": "UCR2",
      "attributes": {
        "context": "N-terminus of UCR2"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_092",
      "type": "Compound",
      "name": "ERK1/2",
      "attributes": {
        "context": "ERK1/2 phosphorylates a site"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_093",
      "type": "Compound",
      "name": "catalytic domain",
      "attributes": {
        "context": "outer surface of the catalytic domain"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_094",
      "type": "Compound",
      "name": "MK2",
      "attributes": {
        "context": "MK2 phosphorylates a serine"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_095",
      "type": "Compound",
      "name": "serine",
      "attributes": {
        "context": "phosphorylates a serine"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_096",
      "type": "Compound",
      "name": "UCR1",
      "attributes": {
        "context": "within UCR1"
      },
      "source_chunk_ids": [
        "c33fcd1c73a9750ca6fd762f8f49b413"
      ]
    },
    {
      "id": "ent_097",
      "type": "PharmEffect",
      "name": "inhibit dimerization",
      "attributes": {
        "context": "their protein partners would restrict access to these surfaces and thereby inhibit dimerization."
      },
      "source_chunk_ids": [
        "6f9348c4f2c86e2dd7280a636abd9a1a"
      ]
    },
    {
      "id": "ent_098",
      "type": "PharmEffect",
      "name": "blocking dimerization",
      "attributes": {
        "context": "the dimerization of PDE4D5 was blocked by two well-characterized protein partners"
      },
      "source_chunk_ids": [
        "6f9348c4f2c86e2dd7280a636abd9a1a"
      ]
    },
    {
      "id": "ent_099",
      "type": "PharmEffect",
      "name": "preventing it from forming a dimer",
      "attributes": {
        "context": "possibly by sequestering the monomeric protein and thereby preventing it from forming a dimer"
      },
      "source_chunk_ids": [
        "6f9348c4f2c86e2dd7280a636abd9a1a"
      ]
    },
    {
      "id": "ent_100",
      "type": "PharmEffect",
      "name": "Inhibiting the dimerization",
      "attributes": {
        "context": "Inhibiting the dimerization of PDE4D5 could have multiple possible functional roles"
      },
      "source_chunk_ids": [
        "6f9348c4f2c86e2dd7280a636abd9a1a"
      ]
    },
    {
      "id": "ent_101",
      "type": "PharmEffect",
      "name": "increasing the enzymatic activity",
      "attributes": {
        "context": "such as increasing the enzymatic activity of PDE4D5 in certain cellular contexts"
      },
      "source_chunk_ids": [
        "6f9348c4f2c86e2dd7280a636abd9a1a"
      ]
    },
    {
      "id": "ent_102",
      "type": "Compound",
      "name": "RACK1",
      "attributes": {
        "context": "RACK1 and \u03b2-arrestin2 have very different avidities"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_103",
      "type": "Compound",
      "name": "\u03b2-arrestin2",
      "attributes": {
        "context": "RACK1 and \u03b2-arrestin2 have very different avidities"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_104",
      "type": "Compound",
      "name": "PDE4D5",
      "attributes": {
        "context": "conformation of PDE4D5"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_105",
      "type": "Compound",
      "name": "GRK2",
      "attributes": {
        "context": "GRK2-phosphorylated state"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_106",
      "type": "Compound",
      "name": "\u03b2_2-adrenergic receptor",
      "attributes": {
        "context": "state of the \u03b2_2-adrenergic receptor"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_107",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "down-regulate cAMP signaling"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_108",
      "type": "PharmEffect",
      "name": "down-regulate cAMP signaling",
      "attributes": {
        "context": "thereby down-regulate cAMP signaling"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_109",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "move PDE4 enzymatic activity"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_110",
      "type": "PharmEffect",
      "name": "catalytic activity",
      "attributes": {
        "context": "much higher catalytic activity"
      },
      "source_chunk_ids": [
        "c418126e5189e05c5e8be5ddd9686294"
      ]
    },
    {
      "id": "ent_111",
      "type": "Compound",
      "name": "PDE4s",
      "attributes": {
        "context": "functions of the PDE4s"
      },
      "source_chunk_ids": [
        "0f435dcc974c23755811135ecd26ddfa"
      ]
    },
    {
      "id": "ent_112",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "that cAMP binds to"
      },
      "source_chunk_ids": [
        "0f435dcc974c23755811135ecd26ddfa"
      ]
    },
    {
      "id": "ent_113",
      "type": "Compound",
      "name": "cAMP-dependent protein kinase",
      "attributes": {
        "context": "subunit of cAMP-dependent protein kinase (kinase A; PKA)"
      },
      "source_chunk_ids": [
        "0f435dcc974c23755811135ecd26ddfa"
      ]
    },
    {
      "id": "ent_114",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "kinase A; PKA"
      },
      "source_chunk_ids": [
        "0f435dcc974c23755811135ecd26ddfa"
      ]
    },
    {
      "id": "ent_115",
      "type": "Compound",
      "name": "Epac",
      "attributes": {
        "context": "activated by cAMP (Epac"
      },
      "source_chunk_ids": [
        "0f435dcc974c23755811135ecd26ddfa"
      ]
    },
    {
      "id": "ent_116",
      "type": "Compound",
      "name": "cAMP-gated ion channels",
      "attributes": {
        "context": "cAMP-gated ion channels"
      },
      "source_chunk_ids": [
        "0f435dcc974c23755811135ecd26ddfa"
      ]
    },
    {
      "id": "ent_117",
      "type": "Compound",
      "name": "Rap1",
      "attributes": {
        "context": "factor for Rap1"
      },
      "source_chunk_ids": [
        "0f435dcc974c23755811135ecd26ddfa"
      ]
    },
    {
      "id": "ent_118",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "cAMP can regulate ion channel activity"
      },
      "source_chunk_ids": [
        "51dcc37a1ef9c2c62c09059421e5a3b3"
      ]
    },
    {
      "id": "ent_119",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "phosphorylated by PKA"
      },
      "source_chunk_ids": [
        "51dcc37a1ef9c2c62c09059421e5a3b3"
      ]
    },
    {
      "id": "ent_120",
      "type": "Compound",
      "name": "cystic fibrosis transmembrane regulator (CFTR)",
      "attributes": {
        "context": "the cystic fibrosis transmembrane regulator (CFTR)"
      },
      "source_chunk_ids": [
        "51dcc37a1ef9c2c62c09059421e5a3b3"
      ]
    },
    {
      "id": "ent_121",
      "type": "Compound",
      "name": "Cl-",
      "attributes": {
        "context": "a Cl- ion channel"
      },
      "source_chunk_ids": [
        "51dcc37a1ef9c2c62c09059421e5a3b3"
      ]
    },
    {
      "id": "ent_122",
      "type": "Indication",
      "name": "cystic fibrosis",
      "attributes": {
        "context": "mutated in the disease cystic fibrosis"
      },
      "source_chunk_ids": [
        "51dcc37a1ef9c2c62c09059421e5a3b3"
      ]
    },
    {
      "id": "ent_123",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "A number of PDE4 isoforms"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_124",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "other than PDE4B1"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_125",
      "type": "PharmEffect",
      "name": "synaptic function",
      "attributes": {
        "context": "implicated in synaptic function"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_126",
      "type": "PharmEffect",
      "name": "hippocampal functions",
      "attributes": {
        "context": "in hippocampal functions"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_127",
      "type": "PharmEffect",
      "name": "learning",
      "attributes": {
        "context": "essential to learning"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_128",
      "type": "PharmEffect",
      "name": "memory",
      "attributes": {
        "context": "learning and memory"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_129",
      "type": "Compound",
      "name": "PDE4B3",
      "attributes": {
        "context": "the PDE4B3 isoform"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_130",
      "type": "PharmEffect",
      "name": "LTP",
      "attributes": {
        "context": "implicated in LTP"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_131",
      "type": "PharmEffect",
      "name": "late-phase LTP",
      "attributes": {
        "context": "especially late-phase LTP"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_132",
      "type": "Compound",
      "name": "gravin",
      "attributes": {
        "context": "anchoring protein gravin"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_133",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "containing PKA"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_134",
      "type": "Compound",
      "name": "PKC",
      "attributes": {
        "context": "PKC, calmodulin"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_135",
      "type": "Compound",
      "name": "calmodulin",
      "attributes": {
        "context": "calmodulin, and PDE4D isoforms"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_136",
      "type": "Compound",
      "name": "PDE4D isoforms",
      "attributes": {
        "context": "and PDE4D isoforms"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_137",
      "type": "Compound",
      "name": "\\beta_2-adrenergic receptor",
      "attributes": {
        "context": "to the \\beta_2-adrenergic receptor"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_138",
      "type": "Compound",
      "name": "gravin",
      "attributes": {
        "context": "alpha-isoform of gravin"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_139",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "PKA-dependent long-lasting forms"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_140",
      "type": "PharmEffect",
      "name": "hippocampal synaptic plasticity",
      "attributes": {
        "context": "forms of hippocampal synaptic plasticity"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_141",
      "type": "Compound",
      "name": "\\beta_2-adrenergic receptor",
      "attributes": {
        "context": "\\beta_2-adrenergic receptor-mediated plasticity"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_142",
      "type": "PharmEffect",
      "name": "long-term memory storage",
      "attributes": {
        "context": "impairments of long-term memory storage"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_143",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "different PDE4 isoforms"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_144",
      "type": "PharmEffect",
      "name": "synaptic plasticity",
      "attributes": {
        "context": "in synaptic plasticity"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_145",
      "type": "PharmEffect",
      "name": "learning",
      "attributes": {
        "context": "in learning and memory"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_146",
      "type": "PharmEffect",
      "name": "memory",
      "attributes": {
        "context": "learning and memory"
      },
      "source_chunk_ids": [
        "aaa3ec3577f8999b88c34744a54a7b76"
      ]
    },
    {
      "id": "ent_147",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "role of PDE4 isoforms"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_148",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "in depression and learning"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_149",
      "type": "PharmEffect",
      "name": "learning",
      "attributes": {
        "context": "in depression and learning"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_150",
      "type": "Indication",
      "name": "sleep disorders",
      "attributes": {
        "context": "sleep and sleep disorders"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_151",
      "type": "PharmEffect",
      "name": "memory consolidation",
      "attributes": {
        "context": "role of sleep in memory consolidation"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_152",
      "type": "PharmEffect",
      "name": "memory loss",
      "attributes": {
        "context": "produce memory loss"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_153",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "impairment of cAMP- and PKA-dependent forms"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_154",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "impairment of cAMP- and PKA-dependent forms"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_155",
      "type": "PharmEffect",
      "name": "synaptic plasticity",
      "attributes": {
        "context": "hippocampal synaptic plasticity"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_156",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "increases PDE4 activity"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_157",
      "type": "PharmEffect",
      "name": "memory consolidation deficits",
      "attributes": {
        "context": "prevents memory consolidation deficits"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_158",
      "type": "PharmEffect",
      "name": "PDE4 inhibition",
      "attributes": {
        "context": "benefit of PDE4 inhibition"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_159",
      "type": "PharmEffect",
      "name": "cognition",
      "attributes": {
        "context": "on cognition and memory"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_160",
      "type": "PharmEffect",
      "name": "memory",
      "attributes": {
        "context": "on cognition and memory"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_161",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "as rolipram and other PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_162",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "rolipram and other PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_163",
      "type": "PharmEffect",
      "name": "cognitive function",
      "attributes": {
        "context": "improve cognitive function"
      },
      "source_chunk_ids": [
        "851f753fe138eae49cdef934513e841b"
      ]
    },
    {
      "id": "ent_164",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "The prototypical PDE4 inhibitor rolipram"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_165",
      "type": "Compound",
      "name": "PDE4 inhibitor",
      "attributes": {
        "context": "The prototypical PDE4 inhibitor rolipram"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_166",
      "type": "PharmEffect",
      "name": "antidepressant-like activity",
      "attributes": {
        "context": "its antidepressant-like activity"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_167",
      "type": "Compound",
      "name": "PDE4 inhibitor",
      "attributes": {
        "context": "a highly-selective PDE4 inhibitor"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_168",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Extensive testing of rolipram"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_169",
      "type": "Compound",
      "name": "PDE4-selective inhibitors",
      "attributes": {
        "context": "numerous other PDE4-selective inhibitors"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_170",
      "type": "Compound",
      "name": "tricyclic antidepressants",
      "attributes": {
        "context": "such as tricyclic antidepressants"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_171",
      "type": "Compound",
      "name": "SSRIs",
      "attributes": {
        "context": "SSRIs"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_172",
      "type": "Compound",
      "name": "SNRIs",
      "attributes": {
        "context": "SNRIs"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_173",
      "type": "Compound",
      "name": "PDE4-selective inhibitors",
      "attributes": {
        "context": "Specifically, PDE4-selective inhibitors"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_174",
      "type": "PharmEffect",
      "name": "antidepressant-like activity",
      "attributes": {
        "context": "have antidepressant-like activity"
      },
      "source_chunk_ids": [
        "ce773262d6a8b4e0215039826bd9fc98"
      ]
    },
    {
      "id": "ent_175",
      "type": "Compound",
      "name": "PDE4-selective inhibitors",
      "attributes": {
        "context": "These side effects of PDE4-selective inhibitors"
      },
      "source_chunk_ids": [
        "9f565370dbc85702b0849cc5b49404ee"
      ]
    },
    {
      "id": "ent_176",
      "type": "PharmEffect",
      "name": "gastric acid production",
      "attributes": {
        "context": "gastric acid production and secretory diarrhea"
      },
      "source_chunk_ids": [
        "9f565370dbc85702b0849cc5b49404ee"
      ]
    },
    {
      "id": "ent_177",
      "type": "PharmEffect",
      "name": "secretory diarrhea",
      "attributes": {
        "context": "gastric acid production and secretory diarrhea"
      },
      "source_chunk_ids": [
        "9f565370dbc85702b0849cc5b49404ee"
      ]
    },
    {
      "id": "ent_178",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "elevation of cAMP levels"
      },
      "source_chunk_ids": [
        "9f565370dbc85702b0849cc5b49404ee"
      ]
    },
    {
      "id": "ent_179",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "side effects of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "9f565370dbc85702b0849cc5b49404ee"
      ]
    },
    {
      "id": "ent_180",
      "type": "PharmEffect",
      "name": "emesis",
      "attributes": {
        "context": "experimental studies of emesis"
      },
      "source_chunk_ids": [
        "9f565370dbc85702b0849cc5b49404ee"
      ]
    },
    {
      "id": "ent_181",
      "type": "Compound",
      "name": "siRNA",
      "attributes": {
        "context": "lentiviruses expressing siRNA"
      },
      "source_chunk_ids": [
        "43b8deb8b07bea5fff2ae516fb348a6f"
      ]
    },
    {
      "id": "ent_182",
      "type": "Compound",
      "name": "PDE4 isoform",
      "attributes": {
        "context": "knock down a specific PDE4 isoform"
      },
      "source_chunk_ids": [
        "43b8deb8b07bea5fff2ae516fb348a6f"
      ]
    },
    {
      "id": "ent_183",
      "type": "Compound",
      "name": "Pde4d",
      "attributes": {
        "context": "the Pde4d is essential to memory"
      },
      "source_chunk_ids": [
        "43b8deb8b07bea5fff2ae516fb348a6f"
      ]
    },
    {
      "id": "ent_184",
      "type": "Compound",
      "name": "pCREB",
      "attributes": {
        "context": "regulation of pCREB"
      },
      "source_chunk_ids": [
        "43b8deb8b07bea5fff2ae516fb348a6f"
      ]
    },
    {
      "id": "ent_185",
      "type": "Compound",
      "name": "Pde4d siRNA",
      "attributes": {
        "context": "Pde4d siRNA also has a profound effect"
      },
      "source_chunk_ids": [
        "43b8deb8b07bea5fff2ae516fb348a6f"
      ]
    },
    {
      "id": "ent_186",
      "type": "Compound",
      "name": "PDE4B1 mutant",
      "attributes": {
        "context": "used the over-expression of a dominant-negative PDE4B1 mutant as a transgene"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_187",
      "type": "Compound",
      "name": "PDE4 mutants",
      "attributes": {
        "context": "used dominant-negative PDE4 mutants successfully in cell-based studies"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_188",
      "type": "Compound",
      "name": "PDE4 isoform",
      "attributes": {
        "context": "displace the corresponding endogenous PDE4 isoform from its protein partner(s)"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_189",
      "type": "Compound",
      "name": "Pde4b",
      "attributes": {
        "context": "The murine Pde4b and human PDE4B gene both encode five isoforms"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_190",
      "type": "Compound",
      "name": "PDE4B gene",
      "attributes": {
        "context": "The murine Pde4b and human PDE4B gene both encode five isoforms"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_191",
      "type": "Compound",
      "name": "PDE4B isoforms",
      "attributes": {
        "context": "deficiency of all five PDE4B isoforms"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_192",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "effect(s) of any individual isoform, such as PDE4B1"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_193",
      "type": "Compound",
      "name": "PKA RI\\alpha subunit",
      "attributes": {
        "context": "expressed a dominant-negative PKA RI\\alpha subunit"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_194",
      "type": "Compound",
      "name": "CREB mutant",
      "attributes": {
        "context": "or a dominant-negative CREB mutant"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_195",
      "type": "Compound",
      "name": "CaMKII\\alpha promoter",
      "attributes": {
        "context": "expressed off the CaMKII\\alpha promoter"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_196",
      "type": "Compound",
      "name": "PDE4B1 isoform",
      "attributes": {
        "context": "target just the PDE4B1 isoform"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_197",
      "type": "Compound",
      "name": "Pde4b",
      "attributes": {
        "context": "specificity than a Pde4b knockout"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_198",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "phenotype in PDE4B1 dominant-negative mice"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_199",
      "type": "Compound",
      "name": "Pde4b-/-",
      "attributes": {
        "context": "compared to Pde4b-/- mice"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_200",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "The PDE4B1 dominant-negative transgene clearly produces increased activity"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_201",
      "type": "Compound",
      "name": "pCREB",
      "attributes": {
        "context": "levels of pCREB and neurogenesis"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_202",
      "type": "PharmEffect",
      "name": "increased activity",
      "attributes": {
        "context": "produces increased activity, levels of pCREB and neurogenesis"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_203",
      "type": "PharmEffect",
      "name": "neurogenesis",
      "attributes": {
        "context": "levels of pCREB and neurogenesis"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_204",
      "type": "PharmEffect",
      "name": "antidepressant effects",
      "attributes": {
        "context": "may produce antidepressant effects in several assays"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_205",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "block PDE4B1 function"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_206",
      "type": "Compound",
      "name": "PDE4 isoforms",
      "attributes": {
        "context": "action against other PDE4 isoforms"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_207",
      "type": "Compound",
      "name": "Pde4a",
      "attributes": {
        "context": "encoded by the Pde4a and Pde4d genes"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_208",
      "type": "Compound",
      "name": "Pde4d",
      "attributes": {
        "context": "encoded by the Pde4a and Pde4d genes"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_209",
      "type": "Compound",
      "name": "PDE4 isoform",
      "attributes": {
        "context": "relationship of a PDE4 isoform with its specific interacting partners"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_210",
      "type": "Compound",
      "name": "PDE4B1",
      "attributes": {
        "context": "interaction of PDE4B1 and DISC1"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_211",
      "type": "Compound",
      "name": "DISC1",
      "attributes": {
        "context": "interaction of PDE4B1 and DISC1"
      },
      "source_chunk_ids": [
        "cc972404102f640556454b60c430e9a2"
      ]
    },
    {
      "id": "ent_212",
      "type": "Indication",
      "name": "acrodysostosis",
      "attributes": {
        "context": "patients with acrodysostosis"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_213",
      "type": "Compound",
      "name": "PDE4D",
      "attributes": {
        "context": "PDE4D mutations"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_214",
      "type": "Indication",
      "name": "mental retardation",
      "attributes": {
        "context": "significant mental retardation"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_215",
      "type": "Compound",
      "name": "PRKAR1A",
      "attributes": {
        "context": "PRKAR1A mutations"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_216",
      "type": "Indication",
      "name": "behavioral disorders",
      "attributes": {
        "context": "have behavioral disorders"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_217",
      "type": "Indication",
      "name": "intellectual disorders",
      "attributes": {
        "context": "intellectual disorders in PDE4D acrodysostosis patients"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_218",
      "type": "Indication",
      "name": "skeletal abnormalities",
      "attributes": {
        "context": "skeletal abnormalities"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_219",
      "type": "Indication",
      "name": "intellectual disability",
      "attributes": {
        "context": "involving intellectual disability"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_220",
      "type": "Indication",
      "name": "syndromes",
      "attributes": {
        "context": "additional PDE4D-mutant syndromes"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_221",
      "type": "Indication",
      "name": "CNS",
      "attributes": {
        "context": "affecting the CNS"
      },
      "source_chunk_ids": [
        "5ba3b2ede0dcd3c835ceb6b158ad9c97"
      ]
    },
    {
      "id": "ent_222",
      "type": "Indication",
      "name": "acrodysostosis",
      "attributes": {
        "context": "CNS phenotypes in the acrodysostosis patients"
      },
      "source_chunk_ids": [
        "b1b140f1f4a4d4a112216692c8f52169"
      ]
    },
    {
      "id": "ent_223",
      "type": "Indication",
      "name": "acrodysostosis",
      "attributes": {
        "context": "murine models of the acrodysostosis mutations"
      },
      "source_chunk_ids": [
        "b1b140f1f4a4d4a112216692c8f52169"
      ]
    },
    {
      "id": "ent_224",
      "type": "Indication",
      "name": "skeletal abnormalities",
      "attributes": {
        "context": "rat, which has skeletal abnormalities reminiscent of acrodysostosis"
      },
      "source_chunk_ids": [
        "b1b140f1f4a4d4a112216692c8f52169"
      ]
    },
    {
      "id": "ent_225",
      "type": "Indication",
      "name": "acrodysostosis",
      "attributes": {
        "context": "skeletal abnormalities reminiscent of acrodysostosis"
      },
      "source_chunk_ids": [
        "b1b140f1f4a4d4a112216692c8f52169"
      ]
    },
    {
      "id": "ent_226",
      "type": "Compound",
      "name": "PDE4 enzymes",
      "attributes": {
        "context": "Cellular functions of PDE4 enzymes."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_227",
      "type": "Compound",
      "name": "Cyclic nucleotide phosphodiesterases",
      "attributes": {
        "context": "Cyclic nucleotide phosphodiesterases in health and disease."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_228",
      "type": "Indication",
      "name": "disease",
      "attributes": {
        "context": "Cyclic nucleotide phosphodiesterases in health and disease."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_229",
      "type": "Compound",
      "name": "cAMP phosphodiesterase-4 (PDE4)",
      "attributes": {
        "context": "Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_230",
      "type": "Compound",
      "name": "UCR1",
      "attributes": {
        "context": "requires interfaces located in both the UCR1 and catalytic unit domains."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_231",
      "type": "Compound",
      "name": "catalytic unit domains",
      "attributes": {
        "context": "requires interfaces located in both the UCR1 and catalytic unit domains."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_232",
      "type": "Compound",
      "name": "cAMP-responsive element-binding protein",
      "attributes": {
        "context": "mutation of the cAMP-responsive element-binding protein."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_233",
      "type": "PharmEffect",
      "name": "Deficient long-term memory",
      "attributes": {
        "context": "Deficient long-term memory in mice"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_234",
      "type": "Compound",
      "name": "beta-Arrestin2",
      "attributes": {
        "context": "beta-Arrestin2, interacting with phosphodiesterase 4"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_235",
      "type": "Compound",
      "name": "phosphodiesterase 4",
      "attributes": {
        "context": "beta-Arrestin2, interacting with phosphodiesterase 4"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_236",
      "type": "PharmEffect",
      "name": "regulates synaptic release probability",
      "attributes": {
        "context": "regulates synaptic release probability and presynaptic inhibition by opioids."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_237",
      "type": "PharmEffect",
      "name": "presynaptic inhibition",
      "attributes": {
        "context": "regulates synaptic release probability and presynaptic inhibition by opioids."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_238",
      "type": "Compound",
      "name": "opioids",
      "attributes": {
        "context": "presynaptic inhibition by opioids."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_239",
      "type": "Compound",
      "name": "DISC1-binding proteins",
      "attributes": {
        "context": "DISC1-binding proteins in neural development"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_240",
      "type": "Indication",
      "name": "schizophrenia",
      "attributes": {
        "context": "signalling and schizophrenia."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_241",
      "type": "Compound",
      "name": "DISC1",
      "attributes": {
        "context": "DISC1, PDE4B, and NDE1 at the centrosome and synapse."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_242",
      "type": "Compound",
      "name": "PDE4B",
      "attributes": {
        "context": "DISC1, PDE4B, and NDE1 at the centrosome and synapse."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_243",
      "type": "Compound",
      "name": "NDE1",
      "attributes": {
        "context": "DISC1, PDE4B, and NDE1 at the centrosome and synapse."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_244",
      "type": "Compound",
      "name": "PKA",
      "attributes": {
        "context": "PKA phosphorylation of NDE1 is DISC1/PDE4 dependent"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_245",
      "type": "Compound",
      "name": "DISC1",
      "attributes": {
        "context": "PKA phosphorylation of NDE1 is DISC1/PDE4 dependent"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_246",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "PKA phosphorylation of NDE1 is DISC1/PDE4 dependent"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_247",
      "type": "Compound",
      "name": "LIS1",
      "attributes": {
        "context": "modulates its interaction with LIS1 and NDEL1."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_248",
      "type": "Compound",
      "name": "NDEL1",
      "attributes": {
        "context": "modulates its interaction with LIS1 and NDEL1."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_249",
      "type": "Compound",
      "name": "DISC1",
      "attributes": {
        "context": "mental illness through DISC1."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_250",
      "type": "Indication",
      "name": "mental illness",
      "attributes": {
        "context": "theories of mental illness through DISC1."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_251",
      "type": "Compound",
      "name": "phosphodiesterase 4",
      "attributes": {
        "context": "Expression of phosphodiesterase 4 is altered"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_252",
      "type": "Indication",
      "name": "autism",
      "attributes": {
        "context": "brains of subjects with autism."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_253",
      "type": "Compound",
      "name": "GEBR-7b",
      "attributes": {
        "context": "GEBR-7b, a novel PDE4D selective inhibitor"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_254",
      "type": "Compound",
      "name": "PDE4D selective inhibitor",
      "attributes": {
        "context": "GEBR-7b, a novel PDE4D selective inhibitor"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_255",
      "type": "PharmEffect",
      "name": "improves memory",
      "attributes": {
        "context": "selective inhibitor that improves memory in rodents"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_256",
      "type": "Concentration",
      "name": "non-emetic doses",
      "attributes": {
        "context": "in rodents at non-emetic doses."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_257",
      "type": "Compound",
      "name": "Ca2+/calmodulin-dependent protein kinase",
      "attributes": {
        "context": "histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_258",
      "type": "Compound",
      "name": "phosphodiesterase 4D (PDE4D)",
      "attributes": {
        "context": "Design of phosphodiesterase 4D (PDE4D) allosteric modulators"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_259",
      "type": "Compound",
      "name": "allosteric modulators",
      "attributes": {
        "context": "phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_260",
      "type": "PharmEffect",
      "name": "enhancing cognition",
      "attributes": {
        "context": "allosteric modulators for enhancing cognition with improved safety."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_261",
      "type": "Compound",
      "name": "Roflumilast",
      "attributes": {
        "context": "Roflumilast in symptomatic chronic obstructive pulmonary disease"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_262",
      "type": "Indication",
      "name": "chronic obstructive pulmonary disease",
      "attributes": {
        "context": "symptomatic chronic obstructive pulmonary disease: two randomised clinical trials."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_263",
      "type": "Compound",
      "name": "phosphodiesterases",
      "attributes": {
        "context": "activity of drugs that inhibit phosphodiesterases."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_264",
      "type": "Compound",
      "name": "drugs",
      "attributes": {
        "context": "activity of drugs that inhibit phosphodiesterases."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_265",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "Regulation of cocaine reward by CREB."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_266",
      "type": "Compound",
      "name": "CREB",
      "attributes": {
        "context": "Regulation of cocaine reward by CREB."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_267",
      "type": "Indication",
      "name": "myxomas",
      "attributes": {
        "context": "The complex of myxomas, spotty pigmentation, and endocrine overactivity."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_268",
      "type": "Indication",
      "name": "spotty pigmentation",
      "attributes": {
        "context": "myxomas, spotty pigmentation, and endocrine overactivity."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_269",
      "type": "Indication",
      "name": "endocrine overactivity",
      "attributes": {
        "context": "spotty pigmentation, and endocrine overactivity."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_270",
      "type": "Compound",
      "name": "CREB",
      "attributes": {
        "context": "form of CREB-mediated long-term facilitation"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_271",
      "type": "PharmEffect",
      "name": "long-term facilitation",
      "attributes": {
        "context": "CREB-mediated long-term facilitation can be stabilized"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_272",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "autoinhibited conformation of PDE4."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_273",
      "type": "PharmEffect",
      "name": "impairs hippocampal mossy fiber-CA3 long-term potentiation",
      "attributes": {
        "context": "Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_274",
      "type": "PharmEffect",
      "name": "enhancing cAMP-specific phosphodiesterase 4 activity",
      "attributes": {
        "context": "by enhancing cAMP-specific phosphodiesterase 4 activity."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_275",
      "type": "Compound",
      "name": "cAMP-specific phosphodiesterase 4",
      "attributes": {
        "context": "enhancing cAMP-specific phosphodiesterase 4 activity."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_276",
      "type": "PharmEffect",
      "name": "Inhibition of phosphodiesterase-4 reverses memory deficits",
      "attributes": {
        "context": "Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25\u201335 or Abeta1\u201340 peptide in rats."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_277",
      "type": "Compound",
      "name": "phosphodiesterase-4",
      "attributes": {
        "context": "Inhibition of phosphodiesterase-4 reverses memory deficits"
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_278",
      "type": "Compound",
      "name": "Abeta25\u201335 peptide",
      "attributes": {
        "context": "produced by Abeta25\u201335 or Abeta1\u201340 peptide in rats."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_279",
      "type": "Compound",
      "name": "Abeta1\u201340 peptide",
      "attributes": {
        "context": "produced by Abeta25\u201335 or Abeta1\u201340 peptide in rats."
      },
      "source_chunk_ids": [
        "72b259bd416a82bf31182848ae564380"
      ]
    },
    {
      "id": "ent_280",
      "type": "Compound",
      "name": "Disrupted-in-Schizophrenia 1 (DISC1)",
      "attributes": {
        "context": "Disrupted-in-Schizophrenia 1 (DISC1) regulates spines"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_281",
      "type": "Compound",
      "name": "Rac1",
      "attributes": {
        "context": "via Rac1"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_282",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {
        "context": "spines of the glutamate synapse"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_283",
      "type": "Indication",
      "name": "Schizophrenia",
      "attributes": {
        "context": "Disrupted-in-Schizophrenia 1 (DISC1)"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_284",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {
        "context": "Rolipram in major depressive disorder"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_285",
      "type": "Indication",
      "name": "major depressive disorder",
      "attributes": {
        "context": "Rolipram in major depressive disorder"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_286",
      "type": "Compound",
      "name": "imipramine",
      "attributes": {
        "context": "comparative study with imipramine"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_287",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "Is PDE4 too difficult a drug target?"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_288",
      "type": "PharmEffect",
      "name": "Oxidative stress",
      "attributes": {
        "context": "Oxidative stress employs phosphatidyl inositol 3-kinase"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_289",
      "type": "Compound",
      "name": "phosphatidyl inositol 3-kinase",
      "attributes": {
        "context": "employs phosphatidyl inositol 3-kinase"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_290",
      "type": "Compound",
      "name": "ERK",
      "attributes": {
        "context": "and ERK signalling pathways"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_291",
      "type": "Compound",
      "name": "cAMP phosphodiesterase-4D3 (PDE4D3)",
      "attributes": {
        "context": "activate cAMP phosphodiesterase-4D3 (PDE4D3)"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_292",
      "type": "Compound",
      "name": "Ser239",
      "attributes": {
        "context": "phosphorylation at Ser239"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_293",
      "type": "Compound",
      "name": "Ser579",
      "attributes": {
        "context": "and Ser579"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_294",
      "type": "Compound",
      "name": "cAMP-specific phosphodiesterase HSPDE4D3",
      "attributes": {
        "context": "cAMP-specific phosphodiesterase HSPDE4D3 mutants"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_295",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "changes in rolipram inhibition"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_296",
      "type": "Compound",
      "name": "protein kinase A",
      "attributes": {
        "context": "protein kinase A phosphorylation"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_297",
      "type": "Compound",
      "name": "Ser-54",
      "attributes": {
        "context": "phosphorylation of Ser-54"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_298",
      "type": "Compound",
      "name": "MAP kinase ERK2",
      "attributes": {
        "context": "The MAP kinase ERK2 inhibits"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_299",
      "type": "Compound",
      "name": "cyclic AMP-specific phosphodiesterase HSPDE4D3",
      "attributes": {
        "context": "inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_300",
      "type": "Compound",
      "name": "cyclic adenosine monophosphate",
      "attributes": {
        "context": "down-regulation of cyclic adenosine monophosphate concentrations"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_301",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "compartmentalised cAMP signalling"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_302",
      "type": "Compound",
      "name": "phosphodiesterases 4",
      "attributes": {
        "context": "Crystal structures of phosphodiesterases 4"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_303",
      "type": "Compound",
      "name": "phosphodiesterases 5",
      "attributes": {
        "context": "and 5 in complex with inhibitor"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_304",
      "type": "Compound",
      "name": "3-isobutyl-1-methylxanthine",
      "attributes": {
        "context": "inhibitor 3-isobutyl-1-methylxanthine"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_305",
      "type": "Compound",
      "name": "type 4 phosphodiesterase",
      "attributes": {
        "context": "structures of type 4 phosphodiesterase"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_306",
      "type": "Compound",
      "name": "Protein kinase LKB1",
      "attributes": {
        "context": "Protein kinase LKB1 regulates"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_307",
      "type": "Compound",
      "name": "cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B)",
      "attributes": {
        "context": "The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B)"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_308",
      "type": "PharmEffect",
      "name": "anti-depressant",
      "attributes": {
        "context": "by the anti-depressant rolipram"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_309",
      "type": "Compound",
      "name": "PDE4B cAMP-specific phosphodiesterase, HSPDE4B3",
      "attributes": {
        "context": "human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_310",
      "type": "PharmEffect",
      "name": "Ameliorating effects",
      "attributes": {
        "context": "Ameliorating effects of rolipram"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_311",
      "type": "Indication",
      "name": "impairments of learning and memory",
      "attributes": {
        "context": "induced impairments of learning and memory"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_312",
      "type": "Compound",
      "name": "DISC1",
      "attributes": {
        "context": "DISC1-dependent switch"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_313",
      "type": "Compound",
      "name": "type IV phosphodiesterases",
      "attributes": {
        "context": "involvement of type IV phosphodiesterases"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_314",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "in cocaine-induced sensitization"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_315",
      "type": "PharmEffect",
      "name": "sensitization",
      "attributes": {
        "context": "cocaine-induced sensitization"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_316",
      "type": "Compound",
      "name": "pERK",
      "attributes": {
        "context": "and subsequent pERK expression"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_317",
      "type": "Compound",
      "name": "Angelman ubiquitin ligase",
      "attributes": {
        "context": "Mutation of the Angelman ubiquitin ligase"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_318",
      "type": "Compound",
      "name": "p53",
      "attributes": {
        "context": "increased cytoplasmic p53"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_319",
      "type": "Indication",
      "name": "deficits of contextual learning and long-term potentiation",
      "attributes": {
        "context": "deficits of contextual learning and long-term potentiation"
      },
      "source_chunk_ids": [
        "5325ed436231048a4e9d95074e49a554"
      ]
    },
    {
      "id": "ent_320",
      "type": "Compound",
      "name": "phosphodiesterase type IV isozymes",
      "attributes": {
        "context": "regulation of phosphodiesterase type IV isozymes"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_321",
      "type": "PharmEffect",
      "name": "antidepressant drug treatment",
      "attributes": {
        "context": "antidepressant drug treatment"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_322",
      "type": "Indication",
      "name": "electroconvulsive seizure",
      "attributes": {
        "context": "by electroconvulsive seizure"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_323",
      "type": "Compound",
      "name": "N-methyl-D-aspartate",
      "attributes": {
        "context": "N-methyl-D-aspartate receptor-stimulated"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_324",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "cAMP and cGMP by PDE4"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_325",
      "type": "Compound",
      "name": "cGMP",
      "attributes": {
        "context": "cAMP and cGMP by PDE4"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_326",
      "type": "Compound",
      "name": "PDE4 phosphodiesterases",
      "attributes": {
        "context": "cGMP by PDE4 and PDE2 phosphodiesterases"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_327",
      "type": "Compound",
      "name": "PDE2 phosphodiesterases",
      "attributes": {
        "context": "PDE4 and PDE2 phosphodiesterases"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_328",
      "type": "Compound",
      "name": "DARPP-32",
      "attributes": {
        "context": "DARPP-32: an integrator of neurotransmission"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_329",
      "type": "Compound",
      "name": "cAMP phosphodiesterase",
      "attributes": {
        "context": "dunce cAMP phosphodiesterase"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_330",
      "type": "Compound",
      "name": "cAMP phosphodiesterases",
      "attributes": {
        "context": "related cAMP phosphodiesterases"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_331",
      "type": "PharmEffect",
      "name": "antidepressant administration",
      "attributes": {
        "context": "Chronic antidepressant administration"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_332",
      "type": "Compound",
      "name": "cAMP-specific phosphodiesterase 4A",
      "attributes": {
        "context": "phosphodiesterase 4A and 4B isoforms"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_333",
      "type": "Compound",
      "name": "cAMP-specific phosphodiesterase 4B",
      "attributes": {
        "context": "phosphodiesterase 4A and 4B isoforms"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_334",
      "type": "Compound",
      "name": "GluR1",
      "attributes": {
        "context": "Regulation of GluR1 by the A-kinase"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_335",
      "type": "Compound",
      "name": "A-kinase anchoring protein 79 (AKAP79)",
      "attributes": {
        "context": "A-kinase anchoring protein 79 (AKAP79)"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_336",
      "type": "Indication",
      "name": "long-term depression",
      "attributes": {
        "context": "shares properties with long-term depression"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_337",
      "type": "Compound",
      "name": "Type IV phosphodiesterase inhibitor",
      "attributes": {
        "context": "The Type IV phosphodiesterase inhibitor rolipram"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_338",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "inhibitor rolipram interferes"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_339",
      "type": "PharmEffect",
      "name": "drug-induced conditioned place preference",
      "attributes": {
        "context": "drug-induced conditioned place preference"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_340",
      "type": "PharmEffect",
      "name": "Phosphodiesterase inhibition",
      "attributes": {
        "context": "Phosphodiesterase inhibition rescues chronic"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_341",
      "type": "Indication",
      "name": "chronic cognitive deficits",
      "attributes": {
        "context": "rescues chronic cognitive deficits"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_342",
      "type": "Indication",
      "name": "traumatic brain injury",
      "attributes": {
        "context": "induced by traumatic brain injury"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_343",
      "type": "Indication",
      "name": "Sleep deprivation",
      "attributes": {
        "context": "Sleep deprivation impairs cAMP"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_344",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "impairs cAMP signalling"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_345",
      "type": "Compound",
      "name": "Phosphodiesterase inhibitors",
      "attributes": {
        "context": "Phosphodiesterase inhibitors facilitate memory"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_346",
      "type": "PharmEffect",
      "name": "facilitate memory",
      "attributes": {
        "context": "inhibitors facilitate memory"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_347",
      "type": "Indication",
      "name": "addiction",
      "attributes": {
        "context": "from reward to addiction"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_348",
      "type": "PharmEffect",
      "name": "antidepressant activity",
      "attributes": {
        "context": "Potential antidepressant activity of rolipram"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_349",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "activity of rolipram and other selective"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_350",
      "type": "Compound",
      "name": "cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors",
      "attributes": {
        "context": "cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_351",
      "type": "Compound",
      "name": "Rolipram",
      "attributes": {
        "context": "Rolipram, a novel antidepressant drug"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_352",
      "type": "PharmEffect",
      "name": "antidepressant drug",
      "attributes": {
        "context": "a novel antidepressant drug"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_353",
      "type": "Indication",
      "name": "hypothermia",
      "attributes": {
        "context": "reverses the hypothermia and hypokinesia"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_354",
      "type": "Indication",
      "name": "hypokinesia",
      "attributes": {
        "context": "hypothermia and hypokinesia of monoamine-depleted"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_355",
      "type": "Compound",
      "name": "monoamine",
      "attributes": {
        "context": "hypokinesia of monoamine-depleted mice"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_356",
      "type": "Compound",
      "name": "monoamine receptors",
      "attributes": {
        "context": "beyond postsynaptic monoamine receptors"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_357",
      "type": "Compound",
      "name": "phosphodiesterase-4",
      "attributes": {
        "context": "subfamilies of phosphodiesterase-4"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_358",
      "type": "Compound",
      "name": "inhibitors",
      "attributes": {
        "context": "selectivity of their inhibitors"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_359",
      "type": "Compound",
      "name": "Alpha2A-adrenoceptors",
      "attributes": {
        "context": "Alpha2A-adrenoceptors strengthen working memory"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_360",
      "type": "PharmEffect",
      "name": "strengthen working memory",
      "attributes": {
        "context": "strengthen working memory networks"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_361",
      "type": "Compound",
      "name": "cAMP-HCN channel",
      "attributes": {
        "context": "inhibiting cAMP-HCN channel signaling"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_362",
      "type": "Compound",
      "name": "fluoxetine",
      "attributes": {
        "context": "Chronic fluoxetine stimulates maturation"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_363",
      "type": "Indication",
      "name": "psychiatric disease",
      "attributes": {
        "context": "The psychiatric disease risk factors"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_364",
      "type": "Compound",
      "name": "DISC1",
      "attributes": {
        "context": "factors DISC1 and TNIK interact"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_365",
      "type": "Compound",
      "name": "TNIK",
      "attributes": {
        "context": "DISC1 and TNIK interact to regulate"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_366",
      "type": "Compound",
      "name": "phosphodiesterase-4 inhibitor",
      "attributes": {
        "context": "The phosphodiesterase-4 inhibitor rolipram"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_367",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "inhibitor rolipram reverses Abeta-induced"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_368",
      "type": "Compound",
      "name": "Abeta",
      "attributes": {
        "context": "reverses Abeta-induced cognitive impairment"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_369",
      "type": "Indication",
      "name": "cognitive impairment",
      "attributes": {
        "context": "Abeta-induced cognitive impairment"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_370",
      "type": "PharmEffect",
      "name": "neuroinflammatory responses",
      "attributes": {
        "context": "and neuroinflammatory and apoptotic responses"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_371",
      "type": "PharmEffect",
      "name": "apoptotic responses",
      "attributes": {
        "context": "and apoptotic responses in rats"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_372",
      "type": "Compound",
      "name": "phosphodiesterase 4D splice variants",
      "attributes": {
        "context": "phosphodiesterase 4D splice variants knock-down"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_373",
      "type": "PharmEffect",
      "name": "antidepressant-like effects",
      "attributes": {
        "context": "produces antidepressant-like and cognition-enhancing effects"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_374",
      "type": "PharmEffect",
      "name": "cognition-enhancing effects",
      "attributes": {
        "context": "and cognition-enhancing effects"
      },
      "source_chunk_ids": [
        "eadfaa71ec4c678090c108e64271b81d"
      ]
    },
    {
      "id": "ent_375",
      "type": "Compound",
      "name": "Phosphodiesterase-4D",
      "attributes": {
        "context": "Phosphodiesterase-4D knock-down in the prefrontal cortex alleviates chronic unpredictable stress-induced depressive-like behaviors"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_376",
      "type": "PharmEffect",
      "name": "alleviates depressive-like behaviors",
      "attributes": {
        "context": "Phosphodiesterase-4D knock-down in the prefrontal cortex alleviates chronic unpredictable stress-induced depressive-like behaviors"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_377",
      "type": "PharmEffect",
      "name": "alleviates memory deficits",
      "attributes": {
        "context": "alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_378",
      "type": "Indication",
      "name": "depressive-like behaviors",
      "attributes": {
        "context": "alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_379",
      "type": "Indication",
      "name": "memory deficits",
      "attributes": {
        "context": "alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_380",
      "type": "Compound",
      "name": "phosphodiesterases",
      "attributes": {
        "context": "Influence of phosphodiesterases and cGMP on cAMP generation"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_381",
      "type": "Compound",
      "name": "cGMP",
      "attributes": {
        "context": "Influence of phosphodiesterases and cGMP on cAMP generation"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_382",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "Influence of phosphodiesterases and cGMP on cAMP generation"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_383",
      "type": "Compound",
      "name": "phospholamban",
      "attributes": {
        "context": "phosphorylation of phospholamban and troponin I by 5-HT receptor activation"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_384",
      "type": "Compound",
      "name": "troponin I",
      "attributes": {
        "context": "phosphorylation of phospholamban and troponin I by 5-HT receptor activation"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_385",
      "type": "Compound",
      "name": "5-HT receptor",
      "attributes": {
        "context": "phosphorylation of phospholamban and troponin I by 5-HT receptor activation"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_386",
      "type": "Compound",
      "name": "phosphodiesterase type 4 inhibitor",
      "attributes": {
        "context": "Administration of the phosphodiesterase type 4 inhibitor rolipram into the amygdala"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_387",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Administration of the phosphodiesterase type 4 inhibitor rolipram into the amygdala"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_388",
      "type": "PharmEffect",
      "name": "increases recognition memory persistence",
      "attributes": {
        "context": "rolipram into the amygdala at a specific time interval after learning increases recognition memory persistence"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_389",
      "type": "Compound",
      "name": "NMDA receptors",
      "attributes": {
        "context": "Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_390",
      "type": "Compound",
      "name": "phosphatase",
      "attributes": {
        "context": "Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_391",
      "type": "Compound",
      "name": "kinase",
      "attributes": {
        "context": "Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_392",
      "type": "Compound",
      "name": "PDE4",
      "attributes": {
        "context": "PDE4 inhibition enhances hippocampal synaptic plasticity in vivo"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_393",
      "type": "PharmEffect",
      "name": "enhances hippocampal synaptic plasticity",
      "attributes": {
        "context": "PDE4 inhibition enhances hippocampal synaptic plasticity in vivo"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_394",
      "type": "Compound",
      "name": "MK801",
      "attributes": {
        "context": "rescues MK801-induced impairment of long-term potentiation and object recognition memory"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_395",
      "type": "PharmEffect",
      "name": "rescues impairment of long-term potentiation",
      "attributes": {
        "context": "rescues MK801-induced impairment of long-term potentiation and object recognition memory"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_396",
      "type": "PharmEffect",
      "name": "rescues impairment of object recognition memory",
      "attributes": {
        "context": "rescues MK801-induced impairment of long-term potentiation and object recognition memory"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_397",
      "type": "Indication",
      "name": "psychosis",
      "attributes": {
        "context": "in an animal model of psychosis"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_398",
      "type": "Compound",
      "name": "phosphodiesterase-4 inhibitors",
      "attributes": {
        "context": "Effects of repeated treatment with phosphodiesterase-4 inhibitors on cAMP signaling"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_399",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "phosphodiesterase-4 inhibitors on cAMP signaling, hippocampal cell proliferation"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_400",
      "type": "Compound",
      "name": "type 4 cyclic nucleotide phosphodiesterases (PDE4s)",
      "attributes": {
        "context": "hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s)"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_401",
      "type": "Compound",
      "name": "RACK1 signaling scaffold protein",
      "attributes": {
        "context": "The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_402",
      "type": "Compound",
      "name": "cAMP-specific phosphodiesterase PDE4D5 isoform",
      "attributes": {
        "context": "interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_403",
      "type": "Compound",
      "name": "noradrenergic",
      "attributes": {
        "context": "Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_404",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_405",
      "type": "Compound",
      "name": "cyclic AMP phosphodiesterase",
      "attributes": {
        "context": "reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_406",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4)"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_407",
      "type": "Compound",
      "name": "cyclic AMP phosphodiesterase (PDE4)",
      "attributes": {
        "context": "regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4)"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_408",
      "type": "Compound",
      "name": "type 4A phosphodiesterase (PDE4A)",
      "attributes": {
        "context": "Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_409",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A)"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_410",
      "type": "Compound",
      "name": "UBE3A",
      "attributes": {
        "context": "An autism-linked mutation disables phosphorylation control of UBE3A"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_411",
      "type": "Indication",
      "name": "autism",
      "attributes": {
        "context": "An autism-linked mutation disables phosphorylation control of UBE3A"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_412",
      "type": "Compound",
      "name": "CREB",
      "attributes": {
        "context": "CREB as a memory modulator: induced expression of a dCREB2 activator isoform"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_413",
      "type": "Compound",
      "name": "dCREB2",
      "attributes": {
        "context": "induced expression of a dCREB2 activator isoform enhances long-term memory"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_414",
      "type": "PharmEffect",
      "name": "enhances long-term memory",
      "attributes": {
        "context": "dCREB2 activator isoform enhances long-term memory in Drosophila"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_415",
      "type": "Compound",
      "name": "GSK-3beta",
      "attributes": {
        "context": "GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_416",
      "type": "Compound",
      "name": "CRMP-2",
      "attributes": {
        "context": "GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_417",
      "type": "Compound",
      "name": "cAMP",
      "attributes": {
        "context": "cAMP signal transduction in the heart: understanding spatial control"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_418",
      "type": "Compound",
      "name": "HCN pacemaker channels",
      "attributes": {
        "context": "agonist specificity of HCN pacemaker channels"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_419",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Results of a phase II study of the antidepressant effect of rolipram"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_420",
      "type": "PharmEffect",
      "name": "antidepressant effect",
      "attributes": {
        "context": "Results of a phase II study of the antidepressant effect of rolipram"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_421",
      "type": "Compound",
      "name": "Cyclic AMP-specific phosphodiesterase-4",
      "attributes": {
        "context": "Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_422",
      "type": "PharmEffect",
      "name": "antidepressant",
      "attributes": {
        "context": "Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_423",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Effects of rolipram on scopolamine-induced impairment of working and reference memory"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_424",
      "type": "Compound",
      "name": "scopolamine",
      "attributes": {
        "context": "Effects of rolipram on scopolamine-induced impairment of working and reference memory"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_425",
      "type": "PharmEffect",
      "name": "impairment of working and reference memory",
      "attributes": {
        "context": "scopolamine-induced impairment of working and reference memory in the radial-arm maze tests"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_426",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "Ontogeny of rolipram-sensitive, low-K(m), cyclic AMP-specific phosphodiesterase"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_427",
      "type": "Compound",
      "name": "cyclic AMP-specific phosphodiesterase",
      "attributes": {
        "context": "Ontogeny of rolipram-sensitive, low-K(m), cyclic AMP-specific phosphodiesterase in rat brain"
      },
      "source_chunk_ids": [
        "31ca7ff4d4dd1ba712802d2c39773761"
      ]
    },
    {
      "id": "ent_428",
      "type": "Compound",
      "name": "rolipram",
      "attributes": {
        "context": "rolipram- sensitive"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_429",
      "type": "Compound",
      "name": "cyclic AMP",
      "attributes": {
        "context": "cyclic AMP specific phosphodiesterase"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_430",
      "type": "Compound",
      "name": "phosphodiesterase",
      "attributes": {
        "context": "cyclic AMP specific phosphodiesterase"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_431",
      "type": "PharmEffect",
      "name": "noradrenergic lesions",
      "attributes": {
        "context": "Effects of noradrenergic lesions"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_432",
      "type": "PharmEffect",
      "name": "sensitive",
      "attributes": {
        "context": "rolipram- sensitive"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_433",
      "type": "Compound",
      "name": "cyclic AMP phosphodiesterase (PDE4)",
      "attributes": {
        "context": "Inhibition of cyclic AMP phosphodiesterase (PDE4)"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_434",
      "type": "Compound",
      "name": "NMDA receptor",
      "attributes": {
        "context": "NMDA receptor antagonism"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_435",
      "type": "PharmEffect",
      "name": "Inhibition",
      "attributes": {
        "context": "Inhibition of cyclic AMP phosphodiesterase"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_436",
      "type": "PharmEffect",
      "name": "reverses memory deficits",
      "attributes": {
        "context": "reverses memory deficits"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_437",
      "type": "PharmEffect",
      "name": "antagonism",
      "attributes": {
        "context": "NMDA receptor antagonism"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_438",
      "type": "Indication",
      "name": "memory deficits",
      "attributes": {
        "context": "reverses memory deficits"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_439",
      "type": "Compound",
      "name": "PDE4D phosphodiesterase enzyme",
      "attributes": {
        "context": "deficient in the PDE4D phosphodiesterase enzyme"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_440",
      "type": "PharmEffect",
      "name": "Antidepressant-like profile",
      "attributes": {
        "context": "Antidepressant-like profile"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_441",
      "type": "PharmEffect",
      "name": "reduced sensitivity",
      "attributes": {
        "context": "reduced sensitivity to rolipram"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_442",
      "type": "Compound",
      "name": "glutamine",
      "attributes": {
        "context": "A glutamine switch mechanism"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_443",
      "type": "Compound",
      "name": "nucleotide",
      "attributes": {
        "context": "nucleotide selectivity"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_444",
      "type": "Compound",
      "name": "phosphodiesterases",
      "attributes": {
        "context": "selectivity by phosphodiesterases"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_445",
      "type": "Compound",
      "name": "phosphodiesterase 4 (PDE4) enzyme",
      "attributes": {
        "context": "Inhibition of the phosphodiesterase 4 (PDE4) enzyme"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_446",
      "type": "Compound",
      "name": "MEK inhibitor U0126",
      "attributes": {
        "context": "infusion of the MEK inhibitor U0126"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_447",
      "type": "Compound",
      "name": "PDE4 inhibitors",
      "attributes": {
        "context": "Effects of the novel PDE4 inhibitors MEM1018 and MEM1091"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_448",
      "type": "Compound",
      "name": "MEM1018",
      "attributes": {
        "context": "novel PDE4 inhibitors MEM1018"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_449",
      "type": "Compound",
      "name": "MEM1091",
      "attributes": {
        "context": "novel PDE4 inhibitors MEM1091"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_450",
      "type": "PharmEffect",
      "name": "inhibitory avoidance",
      "attributes": {
        "context": "inhibitory avoidance tests"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_451",
      "type": "Compound",
      "name": "beta adrenergic agonists",
      "attributes": {
        "context": "beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_452",
      "type": "Compound",
      "name": "cyclic AMP PDE inhibitor rolipram",
      "attributes": {
        "context": "cyclic AMP PDE inhibitor rolipram"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_453",
      "type": "PharmEffect",
      "name": "antidepressant-like behavioral effects",
      "attributes": {
        "context": "antidepressant-like behavioral effects"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_454",
      "type": "Compound",
      "name": "phosphodiesterase-4 enzyme (PDE4)",
      "attributes": {
        "context": "phosphodiesterase-4 enzyme (PDE4)"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_455",
      "type": "PharmEffect",
      "name": "Antidepressant-like effects",
      "attributes": {
        "context": "Antidepressant-like effects of PDE4 inhibitors"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_456",
      "type": "Compound",
      "name": "phosphodiesterase 4B (PDE4B)",
      "attributes": {
        "context": "deficient in phosphodiesterase 4B (PDE4B)"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_457",
      "type": "PharmEffect",
      "name": "Anxiogenic-like behavioral phenotype",
      "attributes": {
        "context": "Anxiogenic-like behavioral phenotype"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_458",
      "type": "Compound",
      "name": "type 4 phosphodiesterase (PDE4)",
      "attributes": {
        "context": "binding to type 4 phosphodiesterase (PDE4)"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_459",
      "type": "Compound",
      "name": "piclamilast",
      "attributes": {
        "context": "using [3H]piclamilast"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_460",
      "type": "PharmEffect",
      "name": "Inhibitor binding",
      "attributes": {
        "context": "Inhibitor binding to type 4 phosphodiesterase"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_461",
      "type": "PharmEffect",
      "name": "Antidepressant-induced increase",
      "attributes": {
        "context": "Antidepressant-induced increase"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_462",
      "type": "PharmEffect",
      "name": "noradrenergic function",
      "attributes": {
        "context": "dependence on noradrenergic and serotonergic function"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_463",
      "type": "PharmEffect",
      "name": "serotonergic function",
      "attributes": {
        "context": "dependence on noradrenergic and serotonergic function"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_464",
      "type": "Compound",
      "name": "Phosphodiesterase 4",
      "attributes": {
        "context": "Phosphodiesterase 4 inhibition"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_465",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {
        "context": "impairs cocaine-induced inhibitory synaptic plasticity"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_466",
      "type": "PharmEffect",
      "name": "inhibition",
      "attributes": {
        "context": "Phosphodiesterase 4 inhibition"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_467",
      "type": "PharmEffect",
      "name": "impairs",
      "attributes": {
        "context": "inhibition impairs cocaine-induced inhibitory synaptic plasticity"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_468",
      "type": "PharmEffect",
      "name": "inhibitory synaptic plasticity",
      "attributes": {
        "context": "cocaine-induced inhibitory synaptic plasticity"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    },
    {
      "id": "ent_469",
      "type": "PharmEffect",
      "name": "conditioned place preference",
      "attributes": {
        "context": "conditioned place preference"
      },
      "source_chunk_ids": [
        "230fb7606d5bc884b238dc6dc00da481"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:03.982965+00:00",
    "original_file": "entities.json"
  }
}